Computer Simulation of Systemic Circulation and Clot Lysis Dynamics During Thrombolytic Therapy That Accounts for Inner Clot Transport and Reaction
- 15 August 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 94 (4) , 763-774
- https://doi.org/10.1161/01.cir.94.4.763
Abstract
Background We developed a computer model to predict lysis rates of thrombi for intravenous thrombolytic regimens based on the convective/diffusive penetration of reacting and adsorbing fibrinolytic species from the circulation into the proximal face of a dissolving clot. Methods and Results Solution of a one-compartment plasma model provided the dynamic concentrations of fibrinolytic species that served as inlet conditions for simulation of the one-dimensional spatiodynamics within a dissolving fibrin clot of defined composition. The model predicted the circulating levels of tissue plasminogen activator (TPA) and plasminogen levels found in clinical trials for various intravenous therapies. To test the model predictions under in vitro conditions, plasma clots were perfused with TPA (0.1 μmol/L) and plasminogen (1.0 μmol/L) delivered at constant permeation velocity of 0.1 or 0.2 mm/min. The model provided an accurate prediction of the measured lysis front movement. For TPA administration regimens used clinically, simulations predicted clot dissolution rates that were consistent with observed reperfusion times. For unidirectional permeation, the continual accumulation of adsorbing species at the moving lysis front due to prior rounds of solubilization and rebinding was predicted to provide for a marked concentration of TPA and plasmin and the eventual depletion of antiplasmin and macroglobulin in an advancing (≈0.25 mm thick) lysis zone. Conclusions Pressure-driven permeation greatly enhances and is a primary determinant of the overall rate of clot lysis and creates a complex local reaction environment at the plasma/clot interface. With simulation of reaction and transport, it becomes possible to quantitatively link the administration regimen, plasminogena activator properties, and thrombolytic outcome.Keywords
This publication has 51 references indexed in Scilit:
- Enzyme‐mediated proteolysis of fibrous biopolymers: Dissolution front movement in fibrin or collagen under conditions of diffusive or convective transportBiotechnology & Bioengineering, 1995
- Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agentJournal of the American College of Cardiology, 1994
- Ultrasound enhancement of thrombolysis and reperfusion in vitroJournal of the American College of Cardiology, 1993
- Composition and Susceptibility to Thrombolysis of Pathological Human Arterial ThrombiAnnals of the New York Academy of Sciences, 1992
- Enhancement of fibrinolysis in vitro by ultrasound.Journal of Clinical Investigation, 1992
- A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.Heart, 1991
- Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1989
- Concentration of protein in fibrin fibers and fibrinogen polymers determined by refractive index matchingBiopolymers, 1986
- Fiberoptic observation of thrombosis and thrombolysis in isolated human coronary arteriesAmerican Heart Journal, 1986
- Local Low-Dose Thrombolytic Therapy of Peripheral Arterial OcclusionsNew England Journal of Medicine, 1982